The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...

Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with fewer side effects.

Till now, the best way to deal with this issue was avoiding the foods you are allergic to whether it is peanuts, milk or sugar. A new study looked at a medicine called omalizumab, usually used for ...

Injectable Drug Resolves Dangerous Food Allergies In One-Third Of Kids By Dennis Thompson HealthDay Reporter MONDAY, March 3, 2025 (HealthDay News) -- More than a third of food-allergic kids were ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an injectable asthma drug, new clinical trial findings report. In all ...

In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, according to phase 2 trial results. Adobe stock/HealthDay ...

New research, led by Johns Hopkins Children’s Center investigators and sponsored by the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID), finds that ...

Omalizumab works by binding to the antibodies that promote allergic reactions, rendering them inactive, researchers said in background notes. The drug has been on the market since 2003 ...